Schedule of Warranty Activity (Details) - $ / shares |
9 Months Ended | 12 Months Ended | |
---|---|---|---|
Sep. 30, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Equity [Abstract] | |||
Warrants Outstanding, Beginning Balance | 191,164 | 199,397 | |
Weighted Average Exercise Price Outstanding, Beginning Balance | $ 93.24 | $ 122.00 | |
Weighted Average Remaining Contractual Life Years, Ending Balance | 2 years 25 days | 1 year 2 months 8 days | 2 years 1 month 6 days |
Warrants, Granted | 151,483 | ||
Weighted Average Exercise Price Outstanding, Granted | $ 6.42 | ||
Warrants,Exercised | |||
Weighted Average Exercise Price Outstanding,Exercised | |||
Warrants, Forfeited or cancelled | (120,604) | (8,233) | |
Weighted Average Exercise Price Outstanding, Forfeited or cancelled | $ 90.72 | ||
Weighted Average Remaining Contractual Life Years, Granted | 2 years 2 months 8 days | ||
Warrants Outstanding, Ending Balance | 222,043 | 191,164 | 199,397 |
Weighted Average Exercise Price Outstanding, Ending Balance | $ 26.48 | $ 93.24 | $ 122.00 |
X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, warrants exercised. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price, Warrants Forfeited or cancelled. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, warrants grants. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual life (years), warrants outstanding grants. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual life (years), warrants outstanding, beginning balance. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|